Large deletions in human BRCA1 gene and use thereof

Details Large deletions in human BRCA1 gene and use thereof Large deletions in human BRCA1 gene and use thereof

2007-07-31

2007-07-31

Foley, Shanon (Department: 1642)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C435S091200

Reexamination Certificate

active

10457839

ABSTRACT:
Large deletions have been identified in the BRCA1 gene in patients. The large deletions predispose the patients to breast cancer and ovarian cancer. Thus, methods for detecting the genetic variants are provided which can be used in detecting a predisposition to cancer.

REFERENCES:
patent: 5622829 (1997-04-01), King et al.
patent: 5821328 (1998-10-01), King et al.
patent: 6150514 (2000-11-01), Swensen
patent: 6512091 (2003-01-01), King et al.
patent: 2002/0198371 (2002-12-01), Wang
patent: WO 98/55650 (1998-12-01), None
Brown, Melissa A. et al., “GermlineBRCA1Promoter Deletions in UK and Australian Familial Breast Cancer Patients: Identification of a Novel Deletion Consistent WithBRCA1:ψBRCA1Recombination”,Human Mutation, 2002; 19:435-442.
Duponchel, Christiane et al., “Rapid Detection by Fluorescent Multiplex PCR of Exon Deletions and Duplications in theC1 InhibitorGene of Hereditary Angioedema Patients”,Human Mutation, 2001; 17:61-70.
Gad, Sophie et al., “Color Bar Coding theBRCA1Gene on Combed DNA: A Useful Strategy for Detecting Large Gene Rearrangements”,Genes, Chromosomes&Cancer, 2001; 31:75-84.
Huber, L. Julie et al., “Impaired DNA Damage Response in Cells Expressing an Exon 11-Deleted Murine Brca1 Variant That Localizes to Nuclear Foci”,Molecular And Cellular Biology, Jun. 2001; 21(12):4005-4015.
Jakubowska, A. et al., “Detection of Germline mutations in the BRCA1 gene by RNA-based sequencing”,Human Mutation, Aug. 2001; 18(2):149-156.
Montagna, Marco et al., “Identification of a 3 kb Alu-mediatedBRCA1gene rearrangement in two breast/ovarian cancer families”,Oncogene, 1999; 18:4160-4165.
Niederacher, Dieter et al., “Patterns of Allelic Loss on Chromosome 17 in Sporadic Breast Carcinomas Detected by Fluorescent-Labeled Microsatellite Analysis”,Genes, Chromosomes&Cancer, 1997; 18:181-192.
Ostrow, K.L. et al., “ABRCA1variant, IVS23+1G→A, causes abnormal RNA splicing by deleting exon 23”,Cancer Genetics and Cytogenetics, 2001; 127:188-190.
Payne, Shannon R. et al., “Complex Germline Rearrangement ofBRCA1Associated with Breast and Ovarian Cancer”,Genes, Chromosomes&Cancer, 2000; 29:58-62.
Petrij-Bosch, Anne et al., “BRCA1genomic deletions are major founder mutations in Dutch breast cancer patients”,Nature Genetics, Nov. 1997; 17:341-345.
Puget, Nadine et al., “A 1-kb Alu-mediated Germ-Line Deletion RemovingBRCA1Exon 17”,Cancer Research, Mar. 1, 1997; 57:828-831.
Puget, Nadine et al., “AnAlu-Mediated 6-kb Duplication in theBRCA1Gene: A New Founder Mutation?”,Am. J. Hum. Genet., 1999; 64:300-302.
Puget, Nadine et al., “Screening for Germ-Line Rearrangements and Regulatory Mutations inBRCA1Led to the Identification of Four New Deletions”,Cancer Research, Jan. 15, 1999; 59:455-461.
Puget, Nadine et al., “DistinctBRCA1Rearrangements Involving theBRCA1Pseudogene Suggest the Existence of a Recombination Hot Spot”,Am. J. Hum. Genet., 2002; 70:858-865.
Rohlfs, Elizabeth M. et al., “AnAlu-Mediated 7.1 kb Deletion ofBRCA1Exons 8 and 9 in Breast and Ovarian Cancer Families That Results in Alternative Splicing of Exon 10”,Genes, Chromosomes&Cancer, 2000; 28:300-307.
Rohlfs, Elizabeth M. et al., “In-frame deletions ofBRCA1may define critical funtional domains”,Hum. Genet., 2002; 107:385-390.
Smith, Todd M. et al., “Complete Genomic Sequence and Analysis of 117 kb of Human DNA Containing the GeneBRCA1”, 1996; 6:1029-1049.
Swensen, Jeff et al., “Identification of a 14 kb deletion involving the promoter region ofBRCA1in breast cancer family”,Human Molecular Genetics, 1997; 6(9):1513-1517.
Thakur, Sanjay et al., “Localization of BRCA1 and a Splice Variant Identifies the Nuclear Localization Signal”,Molecular And Cellular Biology, Jan. 1997; 17(1):444-452.
Wilson, Cindy A. et al., “Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-Δ11b”,Oncogene, 1997; 14:1-16.
Xu, Xiaoling et al., “Centrosome Amplification and a Defective G2-M Cell Cycle Checkpoint Induce Genetic Instability in BRCA1 Exon 11 Isoform-Deficient Cells”,Molecular Cell, Mar. 1999; 3:389-395.

Affiliated with

Also associated with

Rating

Large deletions in human BRCA1 gene and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Large deletions in human BRCA1 gene and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Large deletions in human BRCA1 gene and use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3811677